Hui Hu

1.6k total citations · 1 hit paper
32 papers, 1.3k citations indexed

About

Hui Hu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Hui Hu has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Hui Hu's work include Nanoplatforms for cancer theranostics (5 papers), Extracellular vesicles in disease (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Hui Hu is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Extracellular vesicles in disease (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Hui Hu collaborates with scholars based in China and United States. Hui Hu's co-authors include Yu Chen, Wei Feng, Yuehua Li, Xiaoqin Qian, Luodan Yu, Huijing Xiang, Meiqi Chang, Li Ding, Yuehua Li and Xiuguo Han and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hui Hu

32 papers receiving 1.3k citations

Hit Papers

2D vanadium carbide MXenzyme to alleviate ROS-mediated in... 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Hu China 13 575 530 502 153 138 32 1.3k
Jeremiah Ong’achwa Machuki China 22 757 1.3× 512 1.0× 687 1.4× 100 0.7× 232 1.7× 35 1.6k
Wenjuan Ma China 26 454 0.8× 381 0.7× 1.0k 2.1× 200 1.3× 182 1.3× 53 1.9k
Dong Cen China 14 492 0.9× 246 0.5× 524 1.0× 310 2.0× 174 1.3× 37 1.1k
Zhiyu Zhao China 13 765 1.3× 625 1.2× 392 0.8× 94 0.6× 161 1.2× 24 1.3k
Xiangyu Deng China 21 850 1.5× 327 0.6× 436 0.9× 140 0.9× 213 1.5× 47 1.6k
Shihua Luo China 25 644 1.1× 270 0.5× 906 1.8× 232 1.5× 130 0.9× 73 1.6k
Naishun Liao China 25 656 1.1× 310 0.6× 473 0.9× 167 1.1× 214 1.6× 53 1.4k
Tingsheng Lin China 18 454 0.8× 292 0.6× 281 0.6× 114 0.7× 174 1.3× 26 1.0k
Hualin Fu China 26 561 1.0× 481 0.9× 889 1.8× 316 2.1× 231 1.7× 46 1.9k
Chun Nam Lok Hong Kong 12 349 0.6× 419 0.8× 403 0.8× 150 1.0× 166 1.2× 15 1.6k

Countries citing papers authored by Hui Hu

Since Specialization
Citations

This map shows the geographic impact of Hui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Hu more than expected).

Fields of papers citing papers by Hui Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Hu. The network helps show where Hui Hu may publish in the future.

Co-authorship network of co-authors of Hui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Hu. A scholar is included among the top collaborators of Hui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Hu. Hui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yue, et al.. (2025). The Impact of Triglyceride-Glucose Index Trajectories on Incidence and Recurrent Cardiovascular Events: Evidence from a Retrospective Cohort Study. Vascular Health and Risk Management. Volume 21. 557–570. 1 indexed citations
2.
Li, Haiming, et al.. (2025). Machine learning-based model for the prediction of acute kidney injury following coronary artery bypass graft surgery in elderly Chinese patients. Journal of Thoracic Disease. 17(4). 2519–2527. 1 indexed citations
4.
Hu, Hui, et al.. (2025). Genetic test results and one-year developmental outcomes of fetuses with congenital heart disease. Frontiers in Pediatrics. 13. 1518784–1518784. 1 indexed citations
5.
Hu, Hui, Lili Xia, Xuefei Huang, et al.. (2024). Bionanoengineered 2D monoelemental selenene for piezothrombolysis. Biomaterials. 305. 122468–122468. 8 indexed citations
6.
Liu, Xinping, Hui Hu, Jinjin Chen, et al.. (2024). Engineering of calcium overload for state-of-the-art tumor therapy. Chemical Engineering Journal. 501. 157747–157747. 4 indexed citations
7.
Xiao, Yun, Hui Hu, Wen‐Li Mi, et al.. (2023). 70 The long-term effectiveness of biologics in Chinese patients with psoriasis by body regions: A retrospective real-life study. Journal of Investigative Dermatology. 143(11). S344–S344. 1 indexed citations
8.
Xiao, Fangfei, Xuefeng Gao, Hui Hu, et al.. (2022). Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities. Nutrients. 14(21). 4463–4463. 11 indexed citations
9.
Xiao, Yongmei, et al.. (2022). Case Report: Eosinophilic gastritis with pyloric stenosis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Frontiers in Pediatrics. 10. 1039341–1039341. 2 indexed citations
10.
Jiang, Chunyu, Ruiting Li, Xu Ma, et al.. (2021). Upregulating CXCR7 accelerates endothelial progenitor cell-mediated endothelial repair by activating Akt/Keap-1/Nrf2 signaling in diabetes mellitus. Stem Cell Research & Therapy. 12(1). 264–264. 11 indexed citations
11.
Feng, Wei, Xiuguo Han, Hui Hu, et al.. (2021). 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases. Nature Communications. 12(1). 2203–2203. 426 indexed citations breakdown →
12.
Hu, Hui, Wei Feng, Xiaoqin Qian, et al.. (2021). Emerging Nanomedicine‐Enabled/Enhanced Nanodynamic Therapies beyond Traditional Photodynamics. Advanced Materials. 33(12). e2005062–e2005062. 213 indexed citations
13.
Wang, Ruixue, Yongmei Xiao, Dan Li, et al.. (2020). Clinical and molecular features of children with Beckwith-Wiedemann syndrome in China: a single-center retrospective cohort study. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 46(1). 55–55. 10 indexed citations
14.
Hu, Hui, Luodan Yu, Xiaoqin Qian, et al.. (2020). Chemoreactive Nanotherapeutics by Metal Peroxide Based Nanomedicine. Advanced Science. 8(1). 2000494–2000494. 110 indexed citations
15.
Hu, Hui, et al.. (2019). Transient Ischemic Attack and Carotid Web. American Journal of Neuroradiology. 40(2). 313–318. 26 indexed citations
16.
Hu, Hui, Chunyu Jiang, Ruiting Li, & Jungong Zhao. (2019). Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair.. PubMed. 12(7). 2793–2800. 20 indexed citations
17.
Hu, Hui, et al.. (2018). ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Zhang, Xinyue, Yizhong Wang, Xiaolu Li, et al.. (2018). Safety of fecal microbiota transplantation in Chinese children: A single-center retrospective study.. Europe PMC (PubMed Central). 6(16). 1121–1127. 12 indexed citations
19.
Li, Xiaolu, Xuefeng Gao, Hui Hu, et al.. (2018). Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection. Frontiers in Microbiology. 9. 2622–2622. 28 indexed citations
20.
Zhang, Hongmei, Qing Li, Xiaojian Zhu, et al.. (2016). miR-146b-5p within BCR-ABL1–Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells. Cancer Research. 76(10). 2901–2911. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026